UK Markets closed

AstraZeneca PLC (AZN.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
481.40+9.60 (+2.03%)
At close: 5:29PM CEST
Full screen
Previous close471.80
Bid482.80 x
Ask483.20 x
Day's range467.50 - 485.10
52-week range464.00 - 622.50
Avg. volume502,339
Market cap638.82B
PE ratio (TTM)180.30
EPS (TTM)2.67
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est81.80
  • Financial Times6 hours ago

    [$$] AstraZeneca chief demands clarity on post-Brexit landscape

    The chief executive of AstraZeneca has said uncertainty over the regulatory regime post-Brexit meant the company would "wait to see" before taking some key decisions about further investment ...

  • Reuters15 hours ago

    Moody's takes negative outlook on AstraZeneca's debt

    Moody's Investors Service said on Friday it changed its outlook on AstraZeneca Plc's long-term debt rating to negative from stable, a day after the company's closely watched advanced lung cancer trial failed. Moody's said the change in outlook reflects the increased execution risk present in the company's pipeline and the negative results of the lung cancer trial. AstraZeneca's combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer trial, triggering the biggest ever daily fall in its shares on Thursday.

  • Financial Times18 hours ago

    [$$] AstraZeneca climbs after cancer drug reassessment

    AstraZeneca was Friday's outperformer after a meeting with management helped bolster confidence that investors have been too hasty to write off the drugmaker's flagship cancer treatment. Pascal Soriot, ...

By using Yahoo, you agree that Yahoo and its partners may use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more